Szendzielorz Ewelina, Spiewak Radoslaw
Department of Experimental Dermatology and Cosmetology, Faculty of Pharmacy, Jagiellonian University Medical College, ul. Medyczna 9, 30-688 Krakow, Poland.
Biomolecules. 2025 Jul 28;15(8):1093. doi: 10.3390/biom15081093.
Research results suggest the potential of topical adenosine as a hair-promoting agent. The aim of this study was to examine the available clinical evidence of the efficacy of topical adenosine products in hair loss. This systematic review was conducted in accordance with PRISMA and PICO guidelines and included articles indexed in PubMed, Scopus, and Web of Science. The strength of evidence was assessed according to the GRADE system. Wherever feasible, data were extracted for a meta-analysis. Among 8625 articles returned by the query, 7 clinical trials were identified of topical adenosine (lotion, shampoo) in hair loss. They unanimously reported on a reduction in hair loss and increase in hair density (strength of evidence very low to moderate). A meta-analysis of three eligible trials showed a tendency to increased hair density (OR = 1.03, 95% CI: 0.89-1.20, = 0.68), an increase in thick hair (OR = 1.4, 95% CI: 0.82-2.38, = 0.21) and a decrease in thin hairs (OR = 0.93, 95% CI: 0.61-1.43, = 0.75) after 6 months of alopecia treatment with a 0.75% adenosine lotion. The results from clinical trials published until now suggest that topical adenosine increases hair thickness, reduces excessive hair loss, stimulates hair regrowth, and increases hair density. The overall strength of evidence remains low due to flawed design and small sample sizes in most trials. Nevertheless, topical adenosine products seem worth trying, especially in the case of contraindications or adverse effects to approved medicinal products for hair loss. Further, better designed trials of adenosine in hair loss are warranted.
研究结果表明局部应用腺苷作为一种促进头发生长的药物具有潜力。本研究的目的是考察局部应用腺苷产品治疗脱发疗效的现有临床证据。本系统评价按照PRISMA和PICO指南进行,纳入了PubMed、Scopus和Web of Science索引的文章。根据GRADE系统评估证据的强度。只要可行,就提取数据进行荟萃分析。在检索返回的8625篇文章中,确定了7项关于局部应用腺苷(洗剂、洗发水)治疗脱发的临床试验。这些试验一致报告脱发减少和头发密度增加(证据强度从非常低到中等)。对三项符合条件的试验进行的荟萃分析显示,用0.75%腺苷洗剂治疗脱发6个月后,有头发密度增加的趋势(OR = 1.03,95%CI:0.89 - 1.20,P = 0.68),粗发增加(OR = 1.4,95%CI:0.82 - 2.38,P = 0.21),细发减少(OR = 0.93,95%CI:0.61 - 1.43,P = 0.75)。迄今为止发表的临床试验结果表明,局部应用腺苷可增加头发厚度,减少过度脱发,刺激头发生长,并增加头发密度。由于大多数试验设计存在缺陷且样本量较小,证据的总体强度仍然较低。然而,局部应用腺苷产品似乎值得一试,特别是在对已批准的脱发治疗药物有禁忌或不良反应的情况下。此外,有必要开展设计更完善的腺苷治疗脱发的试验。